Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Martins, J. P. Santos, M. Martins, A. Felgueiras, M. Santos, R.

Seasonal Influenza Vaccine Effectiveness in Persons Aged 15-64 Years: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2023 ∙ Y. Elzouki, A. N. Elshafei, M. N. Aziz, A. Elzouki, I. Waheed, M. A. Farooqui, K. Azad, A. M. Habas, E. Danjuma, M. I.

Seroconversion and safety of Covid-19 vaccines in patients with chronic liver disease and liver transplant: A systematic review

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Gkoufa, A. Lekakis, V. Papatheodoridis, G. Cholongitas, E.

Seroconversion following a booster dose of COVID-19 vaccine in liver transplant recipients. A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Iryaningrum, M. R. Cahyadi, A. Damara, F. A. Bandiara, R. Marbun, M. B. H.

Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2023 ∙ Wang, Y. Chen, D. Pan, Y. Li, H. Zhao, W. Lu, T. Kong, W. Ding, M. Wang, X. Zhang, G.

Serological response and immune-related adverse events following COVID-19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Zhou, Q. Zeng, F. Meng, Y. Liu, Y. Liu, H. Deng, G.

Serological response following COVID-19 vaccines in patients living with HIV: a dose-response meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Mu, Y. Wu, H. Jiang, Z. Liu, K. Xue, X. Zhang, W. Chen, Z.

Serological Responses after a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wu, P. C. Huang, I. H. Wang, C. W. Chung, W. H. Chen, C. B.

Severe Cutaneous Adverse Reactions After COVID-19 Vaccination: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Arabi, M. Al-Najjar, Y. Mhaimeed, N. Salameh, M. A. Paul, P. AlAnni, J. Abdelati, A. A. Laswi, I. Khanjar, B. Al-Ali, D. Elshafeey, A. Mhaimeed, O. Burney, Z. D'Souza, A. Sinha, P. Bhatti, M. Pillai, K. V. Homssi, M. Bshesh, K. Yagan, L. Zakaria, D.

Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Kiely, M. Tadount, F. Lo, E. Sadarangani, M. Wei, S. Q. Rafferty, E. Quach, C. MacDonald, S. E.

Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials

  • Adults
  • Older adults
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...